Does R&D cost for Pharmaceutical Companies Justify the Elevated U.S. Drug Prices?
R&D Cost For Pharmaceutical Companies Do Not Explain Elevated United States Drug Prices. That pharmaceutical companies charge much more for their drugs in the United States than they do in other Western countries has contributed to public and political distrust of their pricing practices. When these higher US prices (which are sometimes cited as being two to five times the prices in Europe) are challenged, the pharmaceutical industry often explains that the higher prices they charge in the US provide them with the funds they need to conduct their high-risk research.
Read More: http://bit.ly/2lVzuXp